Advanced

A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Lip, Gregory Y.; Rasmussen, Lars H.; Olsson, Sol-Britt LU ; Zetterstrand, Sofia; Stahre, Christina; Bylock, Anders; Aunes-Jansson, Maria and Wahlander, Karin (2009) 82nd Scientific Session of the American-Heart-Association In Circulation 120(18). p.1129-1129
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Circulation
volume
120
issue
18
pages
1129 - 1129
publisher
Lippincott Williams and Wilkins
conference name
82nd Scientific Session of the American-Heart-Association
external identifiers
  • wos:000271831504153
ISSN
1524-4539
language
English
LU publication?
yes
id
756a3709-f2bc-4bd1-97bc-89643590a5ae (old id 1568003)
date added to LUP
2010-03-24 11:55:48
date last changed
2016-04-16 02:41:56
@misc{756a3709-f2bc-4bd1-97bc-89643590a5ae,
  author       = {Lip, Gregory Y. and Rasmussen, Lars H. and Olsson, Sol-Britt and Zetterstrand, Sofia and Stahre, Christina and Bylock, Anders and Aunes-Jansson, Maria and Wahlander, Karin},
  issn         = {1524-4539},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {18},
  pages        = {1129--1129},
  publisher    = {Lippincott Williams and Wilkins},
  series       = {Circulation},
  title        = {A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy},
  volume       = {120},
  year         = {2009},
}